Cleared Traditional

K983403 - SALTER LABS NEBULIZER EXHALATION AEROSOL FILTER

K983403 is an FDA 510(k) clearance for SALTER LABS NEBULIZER EXHALATION AEROSO..., manufactured by Salter Labs. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 81-day FDA review.

K983403 · Salter Labs · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1998
Decision
81d
Days
Class 2
Risk

K983403 is an FDA 510(k) clearance for the SALTER LABS NEBULIZER EXHALATION AEROSOL FILTER. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Salter Labs (Arvin, US). The FDA issued a Cleared decision on December 17, 1998 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Salter Labs devices

FDA 510(k) Submission Details - K983403

510(k) Number K983403 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 27, 1998
Decision Date December 17, 1998
Days to Decision 81 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 140d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 407
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K983403.
MABIS NB-02 ULTRASONIC NEBULIZER
K990506 · Mabis Healthcare, Inc. · Mar 1999
TRUMIST BREATH ACTUATED DISPOSABLE NEBULIZER
K982181 · Trudell Medical · Jan 1999
LS SERIES 200 FLOVISION SYSTEM
K971981 · Systam · Dec 1998
METERED DOSE INHALER-REUSABLE MODEL NUMBER RTC 21-A, METERED DOSE INHALER-DISPOSABLE MODEL NUBER RTC 21-D
K981249 · Instrumentation Industries, Inc. · Nov 1998
ICEL EVOLUSONIC PORTABLE ULTRASONIC NEBULIZER
K983736 · Brasamerica Medical Equipment, Inc. · Nov 1998
BRENEB
K982043 · Bremed Italia, S.R.L. · Nov 1998